|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.28 EUR | -0.22% |
|
-0.22% | +5.82% |
| 05-15 | Fine Foods confirms profit; Capex for period over EUR5 million | AN |
| 05-15 | Fine Foods & Pharmaceuticals N.T.M. S.p.A. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Fine Foods & Pharmaceuticals N.T.M. S.p.A. reported earnings results for the nine months ended September 30, 2022. For the nine months, the company reported sales was EUR 152.82 million compared to EUR 144.86 million a year ago. Revenue was EUR 153.14 million compared to EUR 145.07 million a year ago.
Net loss was EUR 11.89 million compared to EUR 2.89 million a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +5.82% | 246M | |
| +14.92% | 8.24B | |
| +3.08% | 7.71B | |
| -24.04% | 4.48B | |
| -9.42% | 3.59B | |
| -19.73% | 3.2B | |
| -8.57% | 1.25B | |
| -25.56% | 1.14B | |
| -8.29% | 885M | |
| -16.10% | 857M |
FINE FOODS & PHARMACEUTICALS N.T.M. S.P.A. 
